Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 1
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2241)
- Volume 19, 2023 (24)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 3, 2007
Acne phototherapy with a 1450-nm diode laser: an open study
Natusko Konishi, Hideki Endo, Naoki Oiso, Shigeru Kawara, Akira Kawada
Therapeutics and Clinical Risk Management 2007, 3:205-209
Published Date: 15 March 2007
Polypharmacy in elderly patients at discharge from the acute care hospital
Andrea Corsonello, Claudio Pedone, Francesco Corica, Raffaele Antonelli Incalzi, On behalf of the Gruppo Italiano di Farmacovigilanza nell’Anziano (GIFA) investigators
Therapeutics and Clinical Risk Management 2007, 3:197-203
Published Date: 15 March 2007
Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH)
Angelo J Cambio, Christopher P Evans
Therapeutics and Clinical Risk Management 2007, 3:181-196
Published Date: 15 March 2007
Hypokalemia secondary to capecitabine: a hidden toxicity?
Muhammad Wasif Saif, Mohammad Houman Fekrazad, Leslie Ledbetter, Robert B Diasio
Therapeutics and Clinical Risk Management 2007, 3:177-180
Published Date: 15 March 2007
What do parents want from their child's asthma treatment?
Stefan Walzer
Therapeutics and Clinical Risk Management 2007, 3:167-175
Published Date: 15 March 2007
Willingness-to-pay for caregivers of children with asthma or wheezing conditions
Stefan Walzer, Peter Zweifel
Therapeutics and Clinical Risk Management 2007, 3:157-165
Published Date: 15 March 2007
Effectiveness and safety of levosulpiride in the treatment of dysmotility-like functional dyspepsia
R Lozano, MG Peralta Concha, A Montealegre, L de Leon, J Ortiz Villalba, et al
Therapeutics and Clinical Risk Management 2007, 3:149-155
Published Date: 15 March 2007
Adalimumab in the treatment of arthritis
Philip J Mease
Therapeutics and Clinical Risk Management 2007, 3:133-148
Published Date: 15 March 2007
Optimal timing for antihypertensive dosing: focus on valsartan
Ramón C Hermida, Diana E Ayala, Carlos Calvo
Therapeutics and Clinical Risk Management 2007, 3:119-131
Published Date: 15 March 2007
Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom
Peter Layer, Jutta Keller, Helena Loeffler, Andreas Kreiss
Therapeutics and Clinical Risk Management 2007, 3:107-118
Published Date: 15 March 2007
Etanercept in the treatment of rheumatoid arthritis
Boulos Haraoui, Vivian Bykerk
Therapeutics and Clinical Risk Management 2007, 3:99-105
Published Date: 15 March 2007
Comparison of echinocandin antifungals
Gregory Eschenauer, Daryl D DePestel, Peggy L Carver
Therapeutics and Clinical Risk Management 2007, 3:71-97
Published Date: 15 March 2007
Venlafaxine extended release (XR) in the treatment of panic disorder
Kevin Kjernisted, Diane McIntosh
Therapeutics and Clinical Risk Management 2007, 3:59-69
Published Date: 15 March 2007
Drug management in chronic rhinosinusitis: identification of the needs
Jean-Baptiste HPJ Watelet, Philippe H Eloy, Paul B van Cauwenberge
Therapeutics and Clinical Risk Management 2007, 3:47-57
Published Date: 15 March 2007
Drug reimportation practices in the United States
Monali J Bhosle, Rajesh Balkrishnan
Therapeutics and Clinical Risk Management 2007, 3:41-46
Published Date: 15 March 2007
Therapy of autoimmune bullous diseases
Diya F Mutasim
Therapeutics and Clinical Risk Management 2007, 3:29-40
Published Date: 15 March 2007
Acute postoperative pain management: focus on iontophoretic transdermal fentanyl
Consalvo Mattia, Flaminia Coluzzi
Therapeutics and Clinical Risk Management 2007, 3:19-27
Published Date: 15 March 2007
Efficacy of Bacillus clausii spores in the prevention of recurrent respiratory infections in children: a pilot study
Gian Luigi Marseglia, Mariangela Tosca, Ignazio Cirillo, Amelia Licari, Maddalena Leone, Alessia Marseglia, Anna Maria Castellazzi, Giorgio Ciprandi
Therapeutics and Clinical Risk Management 2007, 3:13-17
Published Date: 15 March 2007
The use of amisulpride in the treatment of acute psychosis
Philippe Nuss, Martina Hummer, Cédric Tessier
Therapeutics and Clinical Risk Management 2007, 3:3-11
Published Date: 15 March 2007
Editorial ||FREE PAPER||
Garry M Walsh
Therapeutics and Clinical Risk Management 2007, 3:1-2
Published Date: 15 March 2007